Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10415 (
Bcl-2
)
33,771
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Acidosis arises in solid and lymphoid malignancies secondary to altered nutrient supply and utilization. Tumor acidosis correlates with therapeutic resistance, although the mechanism behind this effect is not fully understood. Here we show that incubation of lymphoma cell lines in acidic conditions (pH 6.5) blocks apoptosis induced by multiple cytotoxic metabolic stresses, including deprivation of glucose or glutamine and treatment with dexamethasone. We sought to examine the role of the
Bcl-2
family of apoptosis regulators in this process. Interestingly, we found that acidic culture causes elevation of both
Bcl-2
and Bcl-xL, while also attenuating glutamine starvation-induced elevation of p53-up-regulated modulator of apoptosis (PUMA) and Bim. We confirmed with knockdown studies that these shifts direct survival decisions during starvation and acidosis. Importantly, the promotion of a high anti- to pro-apoptotic
Bcl-2
family member ratio by acidosis renders cells exquisitely sensitive to the
Bcl-2
/Bcl-xL antagonist ABT-737, suggesting that acidosis causes
Bcl-2
family dependence. This dependence appears to be mediated, in part, by the acid-sensing G protein-coupled receptor,
GPR65
, via a MEK/ERK pathway.
...
PMID:Acidosis promotes Bcl-2 family-mediated evasion of apoptosis: involvement of acid-sensing G protein-coupled receptor Gpr65 signaling to Mek/Erk. 2268 89
The tumor microenvironment is generally an acidic environment, yet the effect of extracellular acidosis on chronic lymphocytic leukemia (CLL) is not well established. Here we are the first to report that the extracellular acid sensing G-protein coupled receptor,
GPR65
, is expressed in primary CLL cells where its level correlate strongly with anti-apoptotic
Bcl-2
family member levels.
GPR65
expression is found normally within the lymphoid lineage and has not been previously reported in CLL. We demonstrate a wide range of
GPR65
mRNA expression among CLL 87 patient samples. The correlation between
GPR65
mRNA levels and
Bcl-2
mRNA levels is particularly strong (r=0.8063, p= <0.001). The correlation extends to other anti-apoptotic
Bcl-2
family members, Mcl-1 (r=0.4847, p=0.0010) and Bcl-xl (r=0.3411, p=0.0252), although at lower levels of significance. No correlation is detected between
GPR65
and levels of the pro-apoptotic proteins BIM, PUMA or NOXA.
GPR65
expression also correlates with the favorable prognostic marker of 13q deletion. The present findings suggest the acid sensing receptor
GPR65
may be of significance to allow CLL tolerance of extracellular acidosis. The correlation of
GPR65
with
Bcl-2
suggests a novel cytoprotective mechanism that enables CLL cell adaptation to acidic extracellular conditions. These findings suggest the potential value of targeting
GPR65
therapeutically.
...
PMID:Acidosis Sensing Receptor GPR65 Correlates with Anti-Apoptotic Bcl-2 Family Member Expression in CLL Cells: Potential Implications for the CLL Microenvironment. 2598 52